Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Alcohol consumption may interfere with glycemic control and can exacerbate gastrointestinal side effects
Combining retatrutide with other weight loss medications is not currently recommended and has not been clinically studied in combination therapy
Weight Loss Distribution The results weren't just impressive on averagethey were consistent across the patient population: Weight Loss Thresholds Achieved (12mg dose): 5% weight loss: 94.6% of participants 10% weight loss: 91.3% of participants 15% weight loss: 83.2% of participants 20% weight loss: 73.4% of participants 25% weight loss: 58.6% of participants For comparison, FDA approval for obesity medications typically requires that at least 35% of patients achieve 5% weight loss
Until these trials conclude and data are submitted to regulators, the clinical development of retatrutide remains ongoing and its ultimate approval is not guaranteed
We'll cover the math in more detail shortly
Finding the human and porcine peptide to have identical sequences, the team concluded 'GLP-1 (PG 78-107 amide) from the small intestine seems to be a new hormone with important functions in the control of metabolism and glucose turnover' (rskov, Bersani, Johnson)
US$ 25.81
US$ 28.83
US$ 23.78
US$ 27.62
US$ 23.17
